mRNA-1645-CoreG28v2

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NamemRNA-1645-CoreG28v2
Drug Alias NamemRNA-1645-CoreG28v2core-g28v2 60mer mRNA
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Africa
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInternational Aids Vaccine Initiative
China Registration ClassN/A

Develop Information

Active CompaniesInternational Aids Vaccine Initiative
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A